Conditional approval extended through December 2026 for the treatment of CID in dogs CID confirmatory effectiveness trial ...
Diarrhea is one of the most common reasons for veterinary visits for dogs and the second most common reason for visits to the veterinary emergency room, yet there are currently no FDA-approved drugs ...
Canalevia ®-CA1 is the first and only treatment for CID in dogs to receive any type of approval from the FDA SAN FRANCISCO, CA / ACCESSWIRE / May 11, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" ...
Jaguar Animal Health ( ($JAGX) ) has shared an announcement. On December 8, 2025, Jaguar Health held a Special Meeting where stockholders approved ...
Jaguar Animal Health, which is developing an animal formulation of its parent's approved diarrhea treatment, raised $20 million by offering 2.86 million shares at $7, the low end of its originally ...
SAN FRANCISCO--(BUSINESS WIRE)--Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company"), an animal health company focused on developing and commercializing first-in-class gastrointestinal ...
THIS is the moment a woman aggressively dragged her pet jaguar cub to a shopping centre, which sparked an animal cruelty probe. The disturbing scene unfolded in residential Jalisco, Mexico, which was ...
Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar"), under its Jaguar Animal Health tradename for the veterinary market, today issued a reminder that company personnel are attending the Pet Connect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback